The critical importance of interoperabilityin health care

whitePaper | June 3, 2022

With increased scrutiny from regulatory agencies, advocacy groups and the public for clinical trial transparency, sponsors are feeling the pressure to ramp up efforts to make their studies more accessible.

whitePaper | July 1, 2022

Too often health is something we try not to think about. We avoid talking about it. We put it off for another day, a better time. Then, something unexpected happens: an illness, an unfortunate incident, or even, as we’ve seen these last two and a half years, a pandemic.

whitePaper | December 27, 2022

Year after year, the Life Sciences industry expands at a breakneck pace, with pharmaceutical development leading the way. Regulatory agencies prioritize patient safety in this highly regulated industry.

whitePaper | November 14, 2022

The pandemic has had a disproportionately negative impact on female physicians, the study found. In a multivariable analysis that adjusted for personal characteristics such as age and professional characteristics.

whitePaper | January 21, 2023

Alongside the shift in healthcare toward personalized medicine, 3D print technology has emerged as an invaluable tool for academic medical centers, hospitals, and medical device manufacturers to create patient-specific anatomical models.

whitePaper | March 4, 2020

Health leaders must understand the benefits of their investments in performance improvement projects and the impact on the organization. The traditional approach is most often to measure ROI (return on investment) and, while clearly measurable, is most often related to cost savings or increased revenue and can leave you with an incomplete story. Incorporating VOI (value on investment) enables you to quantify the intangible benefits of your projects and activities making the combination of the two a more robust indicator of project success.